Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Matera

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytesF Malavasi, C Tetta, A Funaro, et al.
Human Immunology|October 1, 1985
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitroF Malavasi, G Bellone, L Matera, et al.
The Journal of the Kentucky Medical Association|November 28, 2007
Tobacco cessation treatment knowledge, attitudes and practices of Kentucky physiciansJamie L Studts, Elizabeth L Matera, Celeste T Worth, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 18, 2000
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patientsG Bellone, C Rollino, S Borsa, et al.
Acta Biomaterialia|January 17, 2020
Myofibroblast activation in synthetic fibrous matrices composed of dextran vinyl sulfoneChristopher D Davidson, Danica Kristen P Jayco, Daniel L Matera, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
BMC Pharmacology & Toxicology|August 16, 2020
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinibA Geneste, M N Duong, L Molina, et al.
Immunology|December 1, 1996
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cellsL Matera, G Bellone, J J Lebren, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytesF Malavasi, C Tetta, A Funaro, et al.
Human Immunology|October 1, 1985
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitroF Malavasi, G Bellone, L Matera, et al.
The Journal of the Kentucky Medical Association|November 28, 2007
Tobacco cessation treatment knowledge, attitudes and practices of Kentucky physiciansJamie L Studts, Elizabeth L Matera, Celeste T Worth, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 18, 2000
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patientsG Bellone, C Rollino, S Borsa, et al.
Acta Biomaterialia|January 17, 2020
Myofibroblast activation in synthetic fibrous matrices composed of dextran vinyl sulfoneChristopher D Davidson, Danica Kristen P Jayco, Daniel L Matera, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Bone Marrow Transplantation|January 1, 1989
Lymphokine activated killer (LAK) activity in lymphoproliferative disordersR Foa, M T Fierro, D Raspadori, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
BMC Pharmacology & Toxicology|August 16, 2020
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinibA Geneste, M N Duong, L Molina, et al.
Immunology|December 1, 1996
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cellsL Matera, G Bellone, J J Lebren, et al.
Pageof 10